3-(3-(4-MORPHOLINYL)PROPYL)-3,4,7,12-TETRAHYDRO-1H-(1,2,5)TRIAZEPINO(1,2-B)PHTHALAZINE-1,5(2H)-DIONE
UNII 2YNZ2J07FT
Substance Identification & Data
This profile provides standardized clinical and technical data for 3-(3-(4-morpholinyl)propyl)-3,4,7,12-tetrahydro-1h-(1,2,5)triazepino(1,2-b)phthalazine-1,5(2h)-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2YNZ2J07FT.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 81215-79-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H26N4O3 LKSOKXVSPAARAE-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3-(3-(4-morpholinyl)propyl)-3,4,7,12-tetrahydro-1h-(1,2,5)triazepino(1,2-b)phthalazine-1,5(2h)-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.